Kim Lincoln

Title: Kim Lincoln: Innovator in Tocopherol Biosynthesis

Introduction

Kim Lincoln is a notable inventor based in University City, MO (US). He has made significant contributions to the field of tocopherol biosynthesis, holding 2 patents that focus on the genetic and biochemical pathways involved in this important process.

Latest Patents

Lincoln's latest patents include "Tocopherol methyltransferase tMT2 and uses thereof" and "Tocopherol biosynthesis related genes and uses thereof." The first patent relates to genes associated with the tocopherol biosynthesis pathway, providing nucleic acid molecules, proteins, and antibodies linked to polypeptides with tocopherol methyltransferase (tMT2) activity. This invention also outlines methods for utilizing these agents in gene isolation, gene analysis, and the production of transgenic plants. Additionally, it includes transgenic plants modified to express the aforementioned polypeptides and methods for producing products from the tocopherol biosynthesis pathway. The second patent similarly focuses on genes associated with the tocopherol biosynthesis pathway, offering methods for gene isolation, gene analysis, and the production of drought-resistant plants.

Career Highlights

Kim Lincoln is currently employed at Monsanto Technology LLC, where he continues to advance research in plant biotechnology. His work has implications for agricultural practices and the development of crops that can withstand environmental stressors.

Collaborations

Lincoln collaborates with esteemed colleagues, including Susan R. Norris and Joshua Stein, contributing to a dynamic research environment that fosters innovation in plant sciences.

Conclusion

Kim Lincoln's work in tocopherol biosynthesis exemplifies the intersection of genetics and agriculture, showcasing the potential for scientific advancements to improve crop resilience and productivity. His contributions are vital to the ongoing evolution of agricultural biotechnology.